{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "Organization",
      "@id": "https://www.curis.com/#organization",
      "name": "Curis, Inc.",
      "url": "https://www.curis.com/",
      "description": "About Curis is a biotechnology company focused on the development and commercialization of innovative therapeutics for the treatment of cancer. We currently have three drug candidates in development: Fimepinostat (formerly known as CUDC-907), an orally available, small molecule inhibitor of HDAC and PI3K enzymes being investigated in a Phase 2 clinical trial in patients with […]"
    },
    {
      "@type": "WebPage",
      "@id": "https://directory.websdocs.com/business/curis-inc#asg",
      "name": "Curis, Inc. ASG Directory Profile",
      "url": "https://directory.websdocs.com/business/curis-inc",
      "isPartOf": {
        "@id": "https://www.curis.com/#organization"
      },
      "description": "Public business information published by the WebsDocs ASG Directory."
    }
  ]
}